Cessatech A/S Sustainability Reports

Cessatech A/S is a clinical-stage pharmaceutical company focused on developing evidence-based and innovative medicines for children. Its primary product candidate is an analgesic nasal spray designed to treat acute and procedural pain in pediatric patients without the need for needles.

Sector: Manufacturing

Country: Denmark

Exchange: Nordic Growth Market

LEI: 549300WO5SKVXWPOXR16

FIGI: BBG00Y3W7833

7 reports from 2020 to 2025

• Cessatech A/S 2025 Annual Report
• Cessatech A/S 2024 Annual Report
• Cessatech A/S 2024 Reporting on the Recommendations on Corporate Governance for Listed Growth Companies from the Danish Association of Listed Growth Companies
• Cessatech A/S 2023 Annual Report
• Cessatech A/S 2022 Annual Report